DSKYF:OTCMKTS
Daiichi Sankyo Co Ltd
16,16 $
arrow_upward
+0,75%(+0,12) 1D
14 қаз., 09:53:55 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DSKYF...
Open
16,16 $
High
16,16 $
Low
16,16 $
Mkt. cap
30,68 млрд
Avg. vol.
3,48 мың
Volume
191,00
52-wk high
29,10 $
52-wk low
13,85 $
Beta
-1,13
Shares outstanding
1,86 млрд
No. of employees
20 мың
Open
16,16 $
High
16,16 $
Low
16,16 $
Mkt. cap
30,68 млрд
Avg. vol.
3,48 мың
Volume
191,00
52-wk high
29,10 $
52-wk low
13,85 $
Beta
-1,13
Shares outstanding
1,86 млрд
No. of employees
20 мың
News stories
From web sources and news partners
Local 3 News
·
1 сағат бұрын
RAW: NYSE: OPENING BELL (WEDNESDAY)
MarketBeat
·
12 минут бұрын
Terrestrial Energy (NASDAQ:IMSR) CEO Acquires $50,869.00 in Stock
Reuters
·
1 сағат бұрын
Wall St opens lower after hot CPI data fuels rate-hike bets
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees20,2 мың
Founded2005 ж. 28 қыр.
HeadquartersChuo City, Токио, Жапония
Sector-
Websitedaiichisankyo.co.jp